Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Lars Viktrup

ResearcherPublications, citations & collaboration network

Lars Viktrup is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 202 works, 6,571 citations, an h-index of 45 and an i10-index of 100.

202
Works
6,571
Citations
45
h-index
100
i10-index

How has Lars Viktrup's publication output changed over time?

ScholarIQpublication output · 1992–2024

Output grew0% over the shown period — from 1 works in 1992 to 1 in 2024.

1
1
1
2
2
1
2
1
19922001200820112012201920202024

What are the most-cited papers on Lars Viktrup?

ScholarIQmost cited works
The symptom of stress incontinence caused by pregnancy or delivery in primiparas.
Lars Viktrup, Gunnar Lose, M Rolff, K. Barfoed
PubMed. 1992316 Citations
Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study
Claus G. Roehrborn, Kevin T. McVary, Albert Elion‐Mboussa, Lars Viktrup
The Journal of Urology. 2008290 Citations
<p>Nerve Growth Factor Signaling and Its Contribution to Pain</p>
Philip A. Barker, Patrick W. Mantyh, Lars Arendt‐Nielsen, Lars Viktrup, Leslie Tive
Journal of Pain Research. 2020248 CitationsOPEN ACCESS
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action
Karl‐Erik Andersson, William C. de Groat, Kevin T. McVary, Tom F. Lue, Mario Maggi, Claus G. Roehrborn, Jean‐Jacques Wyndaele, Thomas Melby, Lars Viktrup
S22797964. 2011224 Citations

Related on ScholarIQ

Eli Lilly (United States)
Institution
The symptom of stress incontinence caused by pregnancy or delivery in primiparas.
Paper
Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial
Paper
Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study
Paper
<p>Nerve Growth Factor Signaling and Its Contribution to Pain</p>
Paper
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action
Paper
470M+ articles · free account